ArticlePloS one2017

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.

Shui-Ping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.